News · Seoul Economic Daily·

Kyung NAM Pharm withdraws rights offering, reviews new fundraising and adjusts new product schedule

Predicted impact: Medium

Withdrawn rights offering and new fundraising review; prior rights offering news already seen.

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.